Prescription of guideline‐directed medical therapy in heart failure: impact on mortality and readmission
Abstract Aims The 2021 European heart failure (HF) guidelines recommend the combination of four drugs as a standard therapy (angiotensin‐converting enzyme inhibitor [ACEI]/angiotensin receptor blocker [ARB]/angiotensin receptor‐neprilysin inhibitor [ARNI]; beta‐blocker (BB); mineralocorticoid recept...
Saved in:
| Main Authors: | Martin Möckel, Samipa Pudasaini, Kristina Feldmann, Henning Thomas Baberg, Benny Levenson, Jürgen Malzahn, Thomas Mansky, Guido Michels, Christian Günster, Elke Jeschke |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-08-01
|
| Series: | ESC Heart Failure |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ehf2.15280 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment adherence in patients older than 65 years who suffer early readmissions
by: Sergio Vicente-Sánchez, et al.
Published: (2018-07-01) -
Readmission Rate, Predictors, Outcomes, and Burden of Readmission of Hepatorenal Syndrome in the United States: A Nationwide Analysis
by: Abdullah Sohail, et al.
Published: (2024-11-01) -
Hypochloraemia and 30 day readmission rate in patients with acute decompensated heart failure
by: Roman Marchenko, et al.
Published: (2020-06-01) -
Impact of systemic lupus erythematosus on adverse outcomes and readmission after total shoulder arthroplasty: a Nationwide Readmission Database analysis 2016–2020
by: Hao-Ming Chang, et al.
Published: (2025-06-01) -
Risk factors and associated outcomes of respiratory ICU readmission
by: Mohamed K. Hasswa, et al.
Published: (2025-05-01)